Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.43 |
| ▸ | AKT1 | P31749 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7258488 | 0.82 | CES2 (0.46) | NFE2L2CES1ALDH1A1CES2TSHR | |
| SCHEMBL27991438 | 0.82 | CA2 (0.47) | NFE2L2CES1ALDH1A1CES2TSHR | |
| SCHEMBL28084535 | 0.82 | NFE2L2 (0.43) | NFE2L2CES1ALDH1A1CES2TSHR | |
| SCHEMBL9077771 | 0.82 | CES2 (0.46) | NFE2L2CES1ALDH1A1CES2TSHR | |
| SCHEMBL28041285 | 0.77 | CES1 (0.47) | NFE2L2CES1ALDH1A1CES2TSHR | |
| SCHEMBL243722 | 0.75 | NFE2L2 (0.70) | NFE2L2CES1ALDH1A1CES2TSHR | |
| SCHEMBL3829338 | 0.75 | NFE2L2 (0.70) | NFE2L2CES1ALDH1A1CES2TSHR | |
| SCHEMBL2593117 | 0.75 | NFE2L2 (0.70) | NFE2L2CES1ALDH1A1CES2TSHR | |
| SCHEMBL63954 | 0.75 | CES1 (0.50) | NFE2L2CES1ALDH1A1CES2TSHR | |
| Hydrochloric Acid SCHEMBL4398755 | 0.73 | NFE2L2 (0.48) | NFE2L2CES1ALDH1A1CES2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1747059-A1 | PERVAPORATION COMPOSITE MEMBRANES | McMaster University (CA) | 2007-01-31 | — | — | EP | claimed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | claimed |
| WO-2005102503-A1 | PERVAPORATION COMPOSITE MEMBRANES | MCMASTER UNIVERSITY (CA) | 2005-11-03 | — | — | WO | claimed |
| EP-2226192-B1 | DRYING SUBSTANCES, PREPARATION AND USE THEREOF | ORIDION MEDICAL 1987 LTD (IL) | 2016-08-31 | — | — | EP | disclosed |
| EP-2226116-B1 | Drying tube, preparation and use thereof | ORIDION MEDICAL 1987 LTD (IL) | 2016-04-20 | — | — | EP | disclosed |
| US-20150283519-A1 | DRYING SUBSTANCES, PREPARATION AND USE THEREOF | ORIDION MEDICAL 1987 LTD. (IL) | 2015-10-08 | — | — | US | disclosed |
| US-9090766-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL 1987 LTD. (IL) | 2015-07-28 | — | — | US | disclosed |
| US-9067035-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL (1987) LTD. (IL) | 2015-06-30 | — | — | US | disclosed |
| US-20140230652-A1 | DRYING SUBSTANCES, PREPARATION AND USE THEREOF | ORIDION MEDICAL (1987) LTD. (IL) | 2014-08-21 | — | — | US | disclosed |
| US-8764888-B2 | Drying substances, preparation and use thereof | ORIDION MEDICAL 1987 LTD. (IL) | 2014-07-01 | — | — | US | disclosed |
| CN-103882543-A | Anti-mite antibacterial thermoplastic polymer melt spun fiber and preparation method thereof | SHANGHAI SYNTHETIC FIBRE RES INST | 2014-06-25 | — | — | CN | disclosed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | disclosed |
| WO-2005102503-A1 | PERVAPORATION COMPOSITE MEMBRANES | MCMASTER UNIVERSITY (CA) | 2005-11-03 | — | — | WO | disclosed |
| US-6369098-B1 | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-.GAMMA. (PPAR.GAMMA.) AND/OR PPAR.ALPHA TREATMENT OF ENDOCRINE, SKIN, CARDIOVASCULAR, IMMUNOLOGICAL, NEUROLOGICAL, NEUROPSYCHIATRIC, NEOPLASTIC AND CHRONIC VIRAL DISEASES OF VARIOUS ORGANS | BETHESDA PHARMACEUTICALS, INC. | 2002-04-09 | — | — | US | disclosed |
| WO-2001025226-A1 | DITHIOLANE DERIVATIVES | BETHESDA PHARMACEUTICALS, INC. (US) | 2001-04-12 | — | — | WO | disclosed |
| US-5767141-A | Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-06-16 | — | — | US | disclosed |
| US-5739147-A | Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-04-14 | — | — | US | disclosed |
| US-5463062-A | Inhibitors of glucose-6-phosphatase system | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-10-31 | — | — | US | disclosed |
| US-4968698-A | FUNGICIDES, ANTIPROTOZOA AGENTS | BURROUGHS WELLCOME CO. (US) | 1990-11-06 | — | — | US | disclosed |
| EP-0170524-A2 | Nitrogen containing heterocyclic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-02-05 | — | — | EP | disclosed |